AustraliaOverall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 4,055 out of 334,837 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 104,442 | 113,363 |
| Total Cites | 5,835 | 6,498 |
| H-index | 39 | 42 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 225 | 229 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1,214 | 1,292 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 1,861 | 1,981 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,735 | 5,132 |
| Ratio of Total Citations to Distinct Citing Papers | 1.23 | 1.27 |
| Self-Citation Percentage |
10.20%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,962 out of 312,644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100,951 | 110,268 |
| Total Cites | 5,227 | 5,797 |
| H-index | 37 | 40 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 221 | 225 |
| Number of Single+First Authored Papers | 39 | 39 |
| Total Cites to Single+First Authored Papers | 1,171 | 1,249 |
| Number of Single+First+Last Authored Papers | 57 | 57 |
| Total Cites to Single+First+Last Authored Papers | 1,781 | 1,900 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,462 | 4,850 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
9.83%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,681 out of 271,773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 92,363 | 101,064 |
| Total Cites | 4,688 | 5,207 |
| H-index | 37 | 40 |
| Hm-index | 13 | 13 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 207 | 211 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1,064 | 1,141 |
| Number of Single+First+Last Authored Papers | 56 | 56 |
| Total Cites to Single+First+Last Authored Papers | 1,619 | 1,732 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 4,007 | 4,359 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.19 |
| Self-Citation Percentage |
9.97%
|
|
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Nuclear Medicine & Medical Imaging
Rank in SubField 1: 3,759 out of 230,678 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 89,947 | 98,389 |
| Total Cites | 4,319 | 4,794 |
| H-index | 35 | 38 |
| Hm-index | 12 | 12 |
| Number of Single Authored Papers | 7 | 7 |
| Total Cites to Single Authored Papers | 200 | 204 |
| Number of Single+First Authored Papers | 38 | 38 |
| Total Cites to Single+First Authored Papers | 1,013 | 1,087 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 1,515 | 1,622 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 3,682 | 4,006 |
| Ratio of Total Citations to Distinct Citing Papers | 1.17 | 1.20 |
| Self-Citation Percentage |
9.91%
|
|
Trending Researchers
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.